FDA Approved: INGREZZA — Original Application (Neurocrine Biosciences, Inc.)

View source ↗

Summary

FDA approved INGREZZA (valbenazine) from Neurocrine Biosciences under NDA209241, marking the original approval for the treatment of tardive dyskinesia. This est…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tardive Dyskinesia

Drugs mentioned

• INGREZZA (valbenazine)

Snippet

ORIG AP for INGREZZA (VALBENAZINE)